INTEGRAGEN (ALINT.PA) Stock Price, Quote, News and Overview
EPA:ALINT - Euronext Paris - Matif - FR0010908723 - Common Stock - Currency: EUR
ALINT.PA Quote, Performance and Key Statistics
EPA:ALINT (6/27/2025, 7:00:00 PM)
0.518
+0.01 (+1.57%)
The current stock price of ALINT.PA is 0.518 EUR. In the past month the price decreased by -21.52%. In the past year, price decreased by -2.26%.
ALINT.PA Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| 4AB.DE | ABBVIE INC | 17.83 | 276.26B | ||
| AMG.DE | AMGEN INC | 13.51 | 128.84B | ||
| GIS.DE | GILEAD SCIENCES INC | 14.28 | 117.43B | ||
| VX1.DE | VERTEX PHARMACEUTICALS INC | N/A | 97.30B | ||
| 1REGN.MI | REGENERON PHARMACEUTICALS | 11.7 | 47.81B | ||
| ARGX.BR | ARGENX SE | 103.6 | 28.91B | ||
| 22UA.DE | BIONTECH SE-ADR | N/A | 21.97B | ||
| IDP.DE | BIOGEN INC | 8.04 | 15.92B | ||
| 0QF.DE | MODERNA INC | N/A | 9.14B | ||
| 1MRNA.MI | MODERNA INC | N/A | 8.99B | ||
| GLPG.AS | GALAPAGOS NV | N/A | 1.57B | ||
| 5CV.DE | CUREVAC NV | 5.66 | 1.03B |
Related stock screener links
About ALINT.PA
Company Profile
IntegraGen SA engages in the development of genetic biomarkers. The company is headquartered in Evry, Ile-De-France. The company went IPO on 2010-06-18. The company researches and develops biomarkers for use as diagnostic tools in the fields of autism, oncology, diabetes and obesity. The company uses an evaluation model with several autism-related genes using a combination of several common polymorphisms (Single-Nucleotide Polymorphism or SNP or common variant). The company also develops molecular biomarker validation programs for Hepatocellular Carcinoma and anti-epidermal growth factor receptor (anti-EGFR) resistance markers. The firm also provides genomics services to practitioners and researchers, such as DNA extraction, marker selection and tagging and bioinformatical analysis of sequence data in such fields as pharmacogenetics, cytogenetics, epigenetics, search for mutations and SNP discovery, among others. As of December 31, 2011, the Company operated through a wholly owned subsidiary, IntegraGen Inc.
Company Info
INTEGRAGEN
Genopole Campus 1 - Genavenir 8 5 Rue Henri Desbrueres
Evry ILE-DE-FRANCE FR
Employees: 44
Phone: 33160910900
INTEGRAGEN / ALINT.PA FAQ
What is the stock price of INTEGRAGEN today?
The current stock price of ALINT.PA is 0.518 EUR. The price increased by 1.57% in the last trading session.
What is the ticker symbol for INTEGRAGEN stock?
The exchange symbol of INTEGRAGEN is ALINT and it is listed on the Euronext Paris - Matif exchange.
On which exchange is ALINT.PA stock listed?
ALINT.PA stock is listed on the Euronext Paris - Matif exchange.
What is INTEGRAGEN worth?
INTEGRAGEN (ALINT.PA) has a market capitalization of 3.49M EUR. This makes ALINT.PA a Nano Cap stock.
How many employees does INTEGRAGEN have?
INTEGRAGEN (ALINT.PA) currently has 44 employees.
What are the support and resistance levels for INTEGRAGEN (ALINT.PA) stock?
INTEGRAGEN (ALINT.PA) has a support level at 0.51 and a resistance level at 0.53. Check the full technical report for a detailed analysis of ALINT.PA support and resistance levels.
Should I buy INTEGRAGEN (ALINT.PA) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of ALINT.PA, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of ALINT.PA, evaluating the profitability, health, valuation and growth aspects
- INTEGRAGEN (ALINT.PA) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- INTEGRAGEN (ALINT.PA) Sales and EPS estimates to see what analysts future expectations are.
- INTEGRAGEN (ALINT.PA) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- INTEGRAGEN (ALINT.PA) Insider and Institutional Ownership to learn about the owners and their transactions.
- INTEGRAGEN (ALINT.PA) Stock Chart to make your own analysis
- INTEGRAGEN (ALINT.PA) Latest news and press-releases to stay up to date.
Does INTEGRAGEN (ALINT.PA) stock pay dividends?
ALINT.PA does not pay a dividend.
What is the Price/Earnings (PE) ratio of INTEGRAGEN (ALINT.PA)?
INTEGRAGEN (ALINT.PA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.01).
ALINT.PA Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to ALINT.PA. When comparing the yearly performance of all stocks, ALINT.PA is a bad performer in the overall market: 71.5% of all stocks are doing better.
ALINT.PA Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to ALINT.PA. The financial health of ALINT.PA is average, but there are quite some concerns on its profitability.
ALINT.PA Financial Highlights
Over the last trailing twelve months ALINT.PA reported a non-GAAP Earnings per Share(EPS) of -0.01. The EPS increased by 50% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -0.48% | ||
| ROE | -1.58% | ||
| Debt/Equity | 0.22 |
ALINT.PA Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 87% to ALINT.PA. The Buy consensus is the average rating of analysts ratings from 9 analysts.